Herantis Pharma has reported new Phase 1b biomarker data that support the expected mechanism of action of HER-096, its…
Articles by Andrea Lobo
GT-02287, an oral therapy being developed by Gain Therapeutics, was associated with improvements in motor function over three months…
Neuralight said a newly completed study showed its machine learning-based system monitoring eye movements via webcam is more sensitive…
Two proteins found on the surface of dopaminergic neurons, the nerve cells that are lost in Parkinson’s disease, may…
A new high-tech imaging tool that can “see” the toxic protein clumps thought responsible for Parkinson’s disease is heading into…
A new collaboration aims to accelerate the development of large-molecule therapeutics capable of entering the brain to treat neurological conditions,…
Zambon Biotech has dosed the first patient in its clinical trial testing Crexont (IPX203) — an extended-release formulation…
GT-02287, an oral therapy being developed by Gain Therapeutics, can increase glucocerebrosidase (GCase) enzyme activity in the brains of…
The Michael J. Fox Foundation (MJFF) has awarded a $1 million research grant to MODAG to advance new…
Biotechnology company Ophidion is teaming up with Neuronasal, a clinical-stage company focused on nose-to-brain delivery of therapies for central…